MedPath

ALOXONE HYDROCHLORIDE SR GASTRO-RESISTANT SUSTAINED RELEASE CAPSULES AS A TREATMENT FOR FUNCTIONAL CONSTIPATION: A RANDOMISED, DOUBLE BLIND CONTROLLED TRIAL IN SECONDARY CARE - The use of Nalcol in functional constipatio

Phase 1
Conditions
Functional constipation
MedDRA version: 11Level: LLTClassification code 10010774Term: Constipation
Registration Number
EUCTR2009-011853-42-GB
Lead Sponsor
orfolk and Norwich University Hospital NHS Trust
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
120
Inclusion Criteria

Inclusion Criteria (all must be met)

Age > 18 years
Male or Female
Satisfy Rome III criteria for functional (slow transit) constipation
Symptoms not relieved by diet and laxatives

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Exclusion Criteria

Severe cardiac, renal or hepatic impairment
Severe psychiatric disturbance
Mental disorder preventing adequate informed consent
Dilatation of the bowel (megarectum or pseudo-obstruction)
Known pregnancy, suspected pregnancy, or trying to conceive
Currently participating (or within 1 month) in any other study

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath